Fibrotech Therapeutics' Acquisition

Fibrotech Therapeutics was acquired by Shire on May 01, 2014.

Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibr…

Articles about Fibrotech Therapeutics' Acquisition: